Glenna Mileson - Net Worth and Insider Trading
Glenna Mileson Net Worth
The estimated net worth of Glenna Mileson is at least $74,335 dollars as of 2024-09-20. Glenna Mileson is the CFO of Athira Pharma Inc and owns about 159,930 shares of Athira Pharma Inc (ATHA) stock worth over $74,335. Details can be seen in Glenna Mileson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Glenna Mileson has not made any transactions after 2022-12-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Glenna Mileson
Glenna Mileson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Glenna Mileson owns 1 companies in total, including Athira Pharma Inc (ATHA) .
Click here to see the complete history of Glenna Mileson’s form 4 insider trades.
Insider Ownership Summary of Glenna Mileson
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ATHA | Athira Pharma Inc | 2022-12-28 | Chief Financial Officer |
Glenna Mileson Latest Holdings Summary
Glenna Mileson currently owns a total of 1 stock. Glenna Mileson owns 159,930 shares of Athira Pharma Inc (ATHA) as of December 28, 2022, with a value of $74,335.
Latest Holdings of Glenna Mileson
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ATHA | Athira Pharma Inc | 2022-12-28 | 159,930 | 0.46 | 74,335 |
Holding Weightings of Glenna Mileson
Glenna Mileson Form 4 Trading Tracker
According to the SEC Form 4 filings, Glenna Mileson has made a total of 2 transactions in Athira Pharma Inc (ATHA) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Athira Pharma Inc is the acquisition of 50,000 shares on December 28, 2022, which cost Glenna Mileson around $142,500.
Insider Trading History of Glenna Mileson
- 1
Glenna Mileson Trading Performance
GuruFocus tracks the stock performance after each of Glenna Mileson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Glenna Mileson is -20.42%. GuruFocus also compares Glenna Mileson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Glenna Mileson within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Glenna Mileson's insider trading performs compared to the benchmark.
Performance of Glenna Mileson
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 44.72 | | | | | |
| Relative Return to S&P 500(%) | 37.12 | | | | | |
Glenna Mileson Ownership Network
Glenna Mileson Owned Company Details
What does Athira Pharma Inc do?
Who are the key executives at Athira Pharma Inc?
Glenna Mileson is the Chief Financial Officer of Athira Pharma Inc. Other key executives at Athira Pharma Inc include See Below Andrew Gengos , Chief Operating Officer Mark James Litton , and Vice President of Discovery Kevin Church .
Athira Pharma Inc (ATHA) Insider Trades Summary
Over the past 18 months, Glenna Mileson made no insider transaction in Athira Pharma Inc (ATHA). Other recent insider transactions involving Athira Pharma Inc (ATHA) include a net purchase of 77,532 shares made by Andrew Gengos , a net sale of 14,672 shares made by Mark James Litton , and a net sale of 7,349 shares made by Mark Worthington .
In summary, during the past 3 months, insiders sold 13,879 shares of Athira Pharma Inc (ATHA) in total and bought 42,400 shares, with a net purchase of 28,521 shares. During the past 18 months, 36,787 shares of Athira Pharma Inc (ATHA) were sold and 758,098 shares were bought by its insiders, resulting in a net purchase of 721,311 shares.
Athira Pharma Inc (ATHA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Athira Pharma Inc Insider Transactions
Glenna Mileson Mailing Address
Above is the net worth, insider trading, and ownership report for Glenna Mileson. You might contact Glenna Mileson via mailing address: 4000 Mason Road, Suite 300, Box 352141, Seattle Wa 98195-2141.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
